Overview

Post Marketing Surveillance Study on Emselex After Launch in Germany

Status:
Completed
Trial end date:
2006-02-01
Target enrollment:
Participant gender:
Summary
- Data are obtained of Emselex in routine treatment of Overactive Bladder. The general objectives are to evaluate the product safety, compatibility, efficacy and patient acceptance.
Details
Lead Sponsor:
Bayer
Treatments:
Darifenacin